Maincare IC Prescription Module Safety Notice
Summary
ANSM issued a safety notice (n° R2609195) informing healthcare services that Maincare Solutions has implemented a security action on its IC prescription module software. Users of the affected software have received direct correspondence from the manufacturer regarding this action.
What changed
ANSM has registered and communicated a safety action by Maincare Solutions affecting users of the IC prescription module software. The action, registered under reference n° R2609195, was implemented by the manufacturer and notified to affected users via direct correspondence dated 02/04/2026.
Healthcare providers using Maincare IC prescription software should review the manufacturer's safety letter and follow any recommended actions or software updates. Questions should be directed to Maincare Solutions as the issuer of the safety action. No specific compliance deadline or penalties are stated in this notice.
What to do next
- Review the safety letter from Maincare Solutions regarding the IC prescription module
- Implement any software updates or corrective measures recommended in the correspondence
- Direct questions about the safety action to Maincare Solutions directly
Source document (simplified)
Information n° R2609195 destinée aux services de soins L'ANSM a été informée de la mise en œuvre d’une action de sécurité effectuée par la société Maincare Solutions.
Les utilisateurs concernés ont reçu le courrier ci-joint.
Cette action de sécurité est enregistrée à l’ANSM sous le n° R2609195.
Pour toute question, merci de vous adresser directement à l’émetteur de l’action de sécurité. Consultez le courrier de la société Maincare Solutions (02/04/2026)
Related changes
Source
Classification
Who this affects
Taxonomy
Browse Categories
Get Pharma & Drug Safety alerts
Weekly digest. AI-summarized, no noise.
Free. Unsubscribe anytime.
Get alerts for this source
We'll email you when ANSM Drug & Device Safety Alerts publishes new changes.